BIOCEPT, INC. Additional Paid in Capital
BIOCEPT, INC. had Additional Paid in Capital of $306.87 million as of 2022-09-30, per its 10-Q/A filed 2023-04-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapital · last filed 2023-04-17
- 2022-09-30: Additional Paid in Capital $306.87M.
- 2022-06-30: Additional Paid in Capital $306.27M.
- 2022-03-31: Additional Paid in Capital $305.59M.
- 2014-12-31: Additional Paid in Capital $138.07M.
| Period end | Additional Paid in Capital |
|---|---|
| 2022-09-30 | $306.87M 10-Q/A · filed 2023-04-17 |
| 2022-06-30 | $306.27M 10-Q/A · filed 2023-04-17 |
| 2022-03-31 | $305.59M 10-Q/A · filed 2023-04-17 |
| 2014-12-31 | $138.07M 10-K · filed 2015-03-11 |
| 2014-09-30 | $137.75M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $137.43M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $136.91M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $109.96M 10-K · filed 2015-03-11 |